APC anti-mouse/human CD44 Antibody APC anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_APC_091907
C57BL/6 mouse splenocytes stained with IM7 APC
  • IM7_APC_091907
    C57BL/6 mouse splenocytes stained with IM7 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103011 25 µg DKK197
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103012 100 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  2. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  3. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  4. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  5. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  6. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  7. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  8. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  9. Yan Y, et al. 2022. Cell Death Differ. 29:1769. PubMed
  10. Li Y, et al. 2022. J Exp Clin Cancer Res. 41:128. PubMed
  11. Campisi L, et al. 2022. Nature. 606:945. PubMed
  12. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  13. Xia KS, et al. 2023. Bioact Mater. 21:69. PubMed
  14. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  15. Liu M, et al. 2022. Cells. 11: . PubMed
  16. Cagle LA, et al. 2023. Front Physiol. 13:1059686. PubMed
  17. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  18. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  19. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  20. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  21. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  22. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  23. Che L, et al. 2023. Foods. 12:. PubMed
  24. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  25. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  26. Liu Y, et al. 2023. Cancers (Basel). 15:. PubMed
  27. Ben-Yaakov H, et al. 2023. Cancers (Basel). 15:. PubMed
  28. Tarafder S, et al. 2023. Bioact Mater. 28:61. PubMed
  29. Tai W, et al. 2023. Nat Commun. 14:2962. PubMed
  30. Yen FC, et al. 2023. Nat Commun. 14:2942. PubMed
  31. Hu Y, et al. 2023. JCI Insight. 8:. PubMed
  32. Pettini E, et al. 2021. Vaccines (Basel). 9:. PubMed
  33. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  34. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
  35. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  36. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  37. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  38. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  39. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  40. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  41. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  42. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  43. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  44. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  45. Nair N, et al. 2020. Curr Protoc Microbiol. 59:e127. PubMed
  46. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  47. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  48. Limon JJ et al. 2019. Cell host & microbe. 25(3):377-388 . PubMed
  49. Li J, et al. 2022. Int J Biol Sci. 18:2091. PubMed
  50. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  51. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  52. Voga M, et al. 2021. Front Vet Sci. 7:610240. PubMed
  53. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  54. Yasuoka T, et al. 2016. PLoS One. 11: 0157395. PubMed
  55. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  56. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  57. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  58. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
  59. Harada Y, et al. 2022. iScience. 25:104021. PubMed
  60. Flaherty S, Reynolds J 2015. J Vis Exp. 98: 52739. PubMed
  61. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  62. Sumigray KD et al. 2018. Developmental cell. 45(2):183-197 . PubMed
  63. Liu H, et al. 2022. Nat Commun. 13:3684. PubMed
  64. Li J, et al. 2020. Cancer Discov. . PubMed
  65. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  66. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  67. Arandjelovic S, et al. 2010. J Leukoc Biol. 88:737. PubMed
  68. Lo PK, et al. 2018. Elife. 7:e31334. PubMed
  69. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  70. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  71. Han Y, et al. 2019. Am J Cancer Res. 9:800. PubMed
  72. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  73. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  74. Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed
  75. Skordos I, et al. 2021. STAR Protocols. 2(1):100351. PubMed
  76. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  77. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  78. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  79. Uhde A, et al. 2016. PLoS One. 11: 0161883. PubMed
  80. Kim HR, et al. 2018. Nat Commun. 9:3630. PubMed
  81. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  82. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  83. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  84. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  85. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  86. Garhyan J, et al. 2015. Am J Pathol. 185: 1924-1934. PubMed
  87. Dai B, et al. 2012. Mol Ther. 20:1800. PubMed
  88. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  89. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  90. Florêncio KGD, et al. 2022. Front Immunol. 13:941757. PubMed
  91. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  92. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  93. Kang DW, et al. 2020. J Pathol. 252:304. PubMed
  94. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  95. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  96. Daly CS, et al. 2018. Oncol Rep. 39:483. PubMed
  97. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  98. Naik A, et al. 2015. J Immunol. 194:790. PubMed
  99. Godavarthy PS, et al. 2019. Haematologica. 104(10). PubMed
  100. Clark GC, et al. 2022. Front Oncol. 12:913656. PubMed
  101. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  102. Long H, et al. 2022. Oncol Lett. 23:95. PubMed
  103. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
  104. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  105. Pastushenko I, et al. 2020. Nature. 589:448. PubMed
  106. Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
  107. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  108. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  109. Cañadas I, et al. 2018. Nat Med. 24:1143. PubMed
  110. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  111. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  112. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  113. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  114. Fei W, et al. 2022. Int J Stem Cells. :. PubMed
  115. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  116. Thakur A, et al. 2018. Front Immunol. 2.336805556. PubMed
  117. Jimenez H, et al. 2019. EBioMedicine. 44:209. PubMed
  118. Revathikumar P, et al. 2018. PLoS One. 13:e0193210. PubMed
  119. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  120. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  121. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  122. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  123. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  124. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  125. Shissler SC, et al. 2020. Sci Rep. 10:8218. PubMed
  126. Yamazaki M, et al. 2021. Biomedicines. 9:. PubMed
  127. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  128. Jeljeli M, et al. 2021. Front Immunol. 12:670776. PubMed
  129. Tian Q, et al. 2022. Cell Death Dis. 13:71. PubMed
  130. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  131. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  132. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  133. Lau J, et al. 2015. Cancer Res . 75: 4302 - 4311. PubMed
  134. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  135. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  136. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  137. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  138. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  139. Kobayashi A, et al. 2011. J Exp Med. 208:2641. PubMed
  140. Hwang WL, et al. 2019. J Hematol Oncol. 12:10. PubMed
  141. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  142. Mizuno M, et al. 2021. Cancers (Basel). 13:. PubMed
  143. Norgard RJ, et al. 2021. EMBO Rep. 22:e51872. PubMed
  144. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  145. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  146. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  147. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  148. Weber K, et al. 2008. J Immunol. 180:1442. PubMed
  149. Gejman RS et al. 2018. eLife. 7 pii: e41090. PubMed
  150. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  151. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  152. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  153. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  154. Gawish R, et al. 2022. Elife. 11:. PubMed
  155. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  156. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  157. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  158. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  159. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  160. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  161. Wang W, et al. 2022. Oxid Med Cell Longev. 2022:8172866. PubMed
  162. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
  163. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  164. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  165. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  166. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  167. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  168. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  169. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  170. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  171. Yan Y, et al. 2022. Cell Death Differ. 29:1769. PubMed
  172. Li Y, et al. 2022. J Exp Clin Cancer Res. 41:128. PubMed
  173. Campisi L, et al. 2022. Nature. 606:945. PubMed
  174. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  175. Xia KS, et al. 2023. Bioact Mater. 21:69. PubMed
  176. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  177. Liu M, et al. 2022. Cells. 11: . PubMed
  178. Cagle LA, et al. 2023. Front Physiol. 13:1059686. PubMed
  179. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  180. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  181. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  182. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  183. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  184. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  185. Che L, et al. 2023. Foods. 12:. PubMed
  186. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  187. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  188. Liu Y, et al. 2023. Cancers (Basel). 15:. PubMed
  189. Ben-Yaakov H, et al. 2023. Cancers (Basel). 15:. PubMed
  190. Tarafder S, et al. 2023. Bioact Mater. 28:61. PubMed
  191. Tai W, et al. 2023. Nat Commun. 14:2962. PubMed
  192. Yen FC, et al. 2023. Nat Commun. 14:2942. PubMed
  193. Hu Y, et al. 2023. JCI Insight. 8:. PubMed
  194. Pettini E, et al. 2021. Vaccines (Basel). 9:. PubMed
  195. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  196. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
  197. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  198. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  199. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  200. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  201. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  202. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  203. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  204. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  205. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  206. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  207. Nair N, et al. 2020. Curr Protoc Microbiol. 59:e127. PubMed
  208. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  209. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  210. Limon JJ et al. 2019. Cell host & microbe. 25(3):377-388 . PubMed
  211. Li J, et al. 2022. Int J Biol Sci. 18:2091. PubMed
  212. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  213. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  214. Voga M, et al. 2021. Front Vet Sci. 7:610240. PubMed
  215. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  216. Yasuoka T, et al. 2016. PLoS One. 11: 0157395. PubMed
  217. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  218. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  219. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  220. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
  221. Harada Y, et al. 2022. iScience. 25:104021. PubMed
  222. Flaherty S, Reynolds J 2015. J Vis Exp. 98: 52739. PubMed
  223. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  224. Sumigray KD et al. 2018. Developmental cell. 45(2):183-197 . PubMed
  225. Liu H, et al. 2022. Nat Commun. 13:3684. PubMed
  226. Li J, et al. 2020. Cancer Discov. . PubMed
  227. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  228. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  229. Arandjelovic S, et al. 2010. J Leukoc Biol. 88:737. PubMed
  230. Lo PK, et al. 2018. Elife. 7:e31334. PubMed
  231. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  232. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  233. Han Y, et al. 2019. Am J Cancer Res. 9:800. PubMed
  234. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  235. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  236. Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed
  237. Skordos I, et al. 2021. STAR Protocols. 2(1):100351. PubMed
  238. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  239. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  240. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  241. Uhde A, et al. 2016. PLoS One. 11: 0161883. PubMed
  242. Kim HR, et al. 2018. Nat Commun. 9:3630. PubMed
  243. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  244. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  245. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  246. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  247. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  248. Garhyan J, et al. 2015. Am J Pathol. 185: 1924-1934. PubMed
  249. Dai B, et al. 2012. Mol Ther. 20:1800. PubMed
  250. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  251. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  252. Florêncio KGD, et al. 2022. Front Immunol. 13:941757. PubMed
  253. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  254. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  255. Kang DW, et al. 2020. J Pathol. 252:304. PubMed
  256. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  257. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  258. Daly CS, et al. 2018. Oncol Rep. 39:483. PubMed
  259. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  260. Naik A, et al. 2015. J Immunol. 194:790. PubMed
  261. Godavarthy PS, et al. 2019. Haematologica. 104(10). PubMed
  262. Clark GC, et al. 2022. Front Oncol. 12:913656. PubMed
  263. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  264. Long H, et al. 2022. Oncol Lett. 23:95. PubMed
  265. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
  266. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  267. Pastushenko I, et al. 2020. Nature. 589:448. PubMed
  268. Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
  269. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  270. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  271. Cañadas I, et al. 2018. Nat Med. 24:1143. PubMed
  272. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  273. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  274. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  275. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  276. Fei W, et al. 2022. Int J Stem Cells. :. PubMed
  277. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  278. Thakur A, et al. 2018. Front Immunol. 2.336805556. PubMed
  279. Jimenez H, et al. 2019. EBioMedicine. 44:209. PubMed
  280. Revathikumar P, et al. 2018. PLoS One. 13:e0193210. PubMed
  281. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  282. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  283. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  284. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  285. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  286. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  287. Shissler SC, et al. 2020. Sci Rep. 10:8218. PubMed
  288. Yamazaki M, et al. 2021. Biomedicines. 9:. PubMed
  289. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  290. Jeljeli M, et al. 2021. Front Immunol. 12:670776. PubMed
  291. Tian Q, et al. 2022. Cell Death Dis. 13:71. PubMed
  292. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  293. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  294. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  295. Lau J, et al. 2015. Cancer Res . 75: 4302 - 4311. PubMed
  296. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  297. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  298. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  299. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  300. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  301. Kobayashi A, et al. 2011. J Exp Med. 208:2641. PubMed
  302. Hwang WL, et al. 2019. J Hematol Oncol. 12:10. PubMed
  303. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  304. Mizuno M, et al. 2021. Cancers (Basel). 13:. PubMed
  305. Norgard RJ, et al. 2021. EMBO Rep. 22:e51872. PubMed
  306. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  307. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  308. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  309. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  310. Weber K, et al. 2008. J Immunol. 180:1442. PubMed
  311. Gejman RS et al. 2018. eLife. 7 pii: e41090. PubMed
  312. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  313. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  314. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  315. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  316. Gawish R, et al. 2022. Elife. 11:. PubMed
  317. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  318. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  319. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  320. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  321. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  322. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  323. Wang W, et al. 2022. Oxid Med Cell Longev. 2022:8172866. PubMed
  324. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
RRID
AB_312962 (BioLegend Cat. No. 103011)
AB_312963 (BioLegend Cat. No. 103012)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark YG™ 581 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark NIR™ 685 anti-mouse/human CD44 (Flexi-Fluor™) Antibody IM7 FC
Spark UV™ 387 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
StarBright UltraViolet 795 anti-mouse/human CD44 IM7 FC
Go To Top Version: 2    Revision Date: 09/11/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_APC_091907
C57BL/6 mouse splenocytes stained with IM7 APC
  • IM7_APC_091907
    C57BL/6 mouse splenocytes stained with IM7 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103011 25 µg DKK197
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103012 100 µg DKK624
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD44 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  2. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  3. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  4. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  5. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  6. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  7. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  8. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  9. Yan Y, et al. 2022. Cell Death Differ. 29:1769. PubMed
  10. Li Y, et al. 2022. J Exp Clin Cancer Res. 41:128. PubMed
  11. Campisi L, et al. 2022. Nature. 606:945. PubMed
  12. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  13. Xia KS, et al. 2023. Bioact Mater. 21:69. PubMed
  14. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  15. Liu M, et al. 2022. Cells. 11: . PubMed
  16. Cagle LA, et al. 2023. Front Physiol. 13:1059686. PubMed
  17. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  18. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  19. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  20. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  21. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  22. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  23. Che L, et al. 2023. Foods. 12:. PubMed
  24. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  25. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  26. Liu Y, et al. 2023. Cancers (Basel). 15:. PubMed
  27. Ben-Yaakov H, et al. 2023. Cancers (Basel). 15:. PubMed
  28. Tarafder S, et al. 2023. Bioact Mater. 28:61. PubMed
  29. Tai W, et al. 2023. Nat Commun. 14:2962. PubMed
  30. Yen FC, et al. 2023. Nat Commun. 14:2942. PubMed
  31. Hu Y, et al. 2023. JCI Insight. 8:. PubMed
  32. Pettini E, et al. 2021. Vaccines (Basel). 9:. PubMed
  33. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  34. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
  35. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  36. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  37. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  38. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  39. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  40. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  41. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  42. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  43. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  44. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  45. Nair N, et al. 2020. Curr Protoc Microbiol. 59:e127. PubMed
  46. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  47. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  48. Limon JJ et al. 2019. Cell host & microbe. 25(3):377-388 . PubMed
  49. Li J, et al. 2022. Int J Biol Sci. 18:2091. PubMed
  50. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  51. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  52. Voga M, et al. 2021. Front Vet Sci. 7:610240. PubMed
  53. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  54. Yasuoka T, et al. 2016. PLoS One. 11: 0157395. PubMed
  55. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  56. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  57. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  58. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
  59. Harada Y, et al. 2022. iScience. 25:104021. PubMed
  60. Flaherty S, Reynolds J 2015. J Vis Exp. 98: 52739. PubMed
  61. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  62. Sumigray KD et al. 2018. Developmental cell. 45(2):183-197 . PubMed
  63. Liu H, et al. 2022. Nat Commun. 13:3684. PubMed
  64. Li J, et al. 2020. Cancer Discov. . PubMed
  65. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  66. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  67. Arandjelovic S, et al. 2010. J Leukoc Biol. 88:737. PubMed
  68. Lo PK, et al. 2018. Elife. 7:e31334. PubMed
  69. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  70. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  71. Han Y, et al. 2019. Am J Cancer Res. 9:800. PubMed
  72. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  73. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  74. Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed
  75. Skordos I, et al. 2021. STAR Protocols. 2(1):100351. PubMed
  76. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  77. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  78. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  79. Uhde A, et al. 2016. PLoS One. 11: 0161883. PubMed
  80. Kim HR, et al. 2018. Nat Commun. 9:3630. PubMed
  81. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  82. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  83. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  84. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  85. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  86. Garhyan J, et al. 2015. Am J Pathol. 185: 1924-1934. PubMed
  87. Dai B, et al. 2012. Mol Ther. 20:1800. PubMed
  88. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  89. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  90. Florêncio KGD, et al. 2022. Front Immunol. 13:941757. PubMed
  91. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  92. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  93. Kang DW, et al. 2020. J Pathol. 252:304. PubMed
  94. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  95. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  96. Daly CS, et al. 2018. Oncol Rep. 39:483. PubMed
  97. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  98. Naik A, et al. 2015. J Immunol. 194:790. PubMed
  99. Godavarthy PS, et al. 2019. Haematologica. 104(10). PubMed
  100. Clark GC, et al. 2022. Front Oncol. 12:913656. PubMed
  101. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  102. Long H, et al. 2022. Oncol Lett. 23:95. PubMed
  103. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
  104. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  105. Pastushenko I, et al. 2020. Nature. 589:448. PubMed
  106. Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
  107. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  108. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  109. Cañadas I, et al. 2018. Nat Med. 24:1143. PubMed
  110. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  111. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  112. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  113. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  114. Fei W, et al. 2022. Int J Stem Cells. :. PubMed
  115. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  116. Thakur A, et al. 2018. Front Immunol. 2.336805556. PubMed
  117. Jimenez H, et al. 2019. EBioMedicine. 44:209. PubMed
  118. Revathikumar P, et al. 2018. PLoS One. 13:e0193210. PubMed
  119. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  120. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  121. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  122. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  123. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  124. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  125. Shissler SC, et al. 2020. Sci Rep. 10:8218. PubMed
  126. Yamazaki M, et al. 2021. Biomedicines. 9:. PubMed
  127. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  128. Jeljeli M, et al. 2021. Front Immunol. 12:670776. PubMed
  129. Tian Q, et al. 2022. Cell Death Dis. 13:71. PubMed
  130. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  131. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  132. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  133. Lau J, et al. 2015. Cancer Res . 75: 4302 - 4311. PubMed
  134. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  135. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  136. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  137. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  138. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  139. Kobayashi A, et al. 2011. J Exp Med. 208:2641. PubMed
  140. Hwang WL, et al. 2019. J Hematol Oncol. 12:10. PubMed
  141. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  142. Mizuno M, et al. 2021. Cancers (Basel). 13:. PubMed
  143. Norgard RJ, et al. 2021. EMBO Rep. 22:e51872. PubMed
  144. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  145. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  146. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  147. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  148. Weber K, et al. 2008. J Immunol. 180:1442. PubMed
  149. Gejman RS et al. 2018. eLife. 7 pii: e41090. PubMed
  150. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  151. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  152. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  153. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  154. Gawish R, et al. 2022. Elife. 11:. PubMed
  155. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  156. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  157. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  158. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  159. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  160. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  161. Wang W, et al. 2022. Oxid Med Cell Longev. 2022:8172866. PubMed
  162. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
  163. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  164. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  165. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
  166. Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
  167. Toubai T, et al. 2017. Blood Adv. 1.095138889. PubMed
  168. Zhou Y, et al. 2021. Methods Mol Biol. 2388:35. PubMed
  169. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  170. Meng J, et al. 2022. Cell Rep. 38:110492. PubMed
  171. Yan Y, et al. 2022. Cell Death Differ. 29:1769. PubMed
  172. Li Y, et al. 2022. J Exp Clin Cancer Res. 41:128. PubMed
  173. Campisi L, et al. 2022. Nature. 606:945. PubMed
  174. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  175. Xia KS, et al. 2023. Bioact Mater. 21:69. PubMed
  176. Kang IH, et al. 2022. iScience. 25:104818. PubMed
  177. Liu M, et al. 2022. Cells. 11: . PubMed
  178. Cagle LA, et al. 2023. Front Physiol. 13:1059686. PubMed
  179. Kasuya T, et al. 2023. Sci Rep. 13:1653. PubMed
  180. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  181. Jiang L, et al. 2021. Nano Today. 36:. PubMed
  182. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  183. Bajaj R, et al. 2022. Cell Rep. 40:111429. PubMed
  184. Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed
  185. Che L, et al. 2023. Foods. 12:. PubMed
  186. Giampaolo S, et al. 2023. iScience. 26:106234. PubMed
  187. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  188. Liu Y, et al. 2023. Cancers (Basel). 15:. PubMed
  189. Ben-Yaakov H, et al. 2023. Cancers (Basel). 15:. PubMed
  190. Tarafder S, et al. 2023. Bioact Mater. 28:61. PubMed
  191. Tai W, et al. 2023. Nat Commun. 14:2962. PubMed
  192. Yen FC, et al. 2023. Nat Commun. 14:2942. PubMed
  193. Hu Y, et al. 2023. JCI Insight. 8:. PubMed
  194. Pettini E, et al. 2021. Vaccines (Basel). 9:. PubMed
  195. Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
  196. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
  197. Hamilton JAG, et al. 2021. Aging Cell. 20:e13309. PubMed
  198. Lechuga-Vieco AV, et al. 2020. Sci Adv. 6:eaba5345. PubMed
  199. Pennock N, et al. 2014. Proc Natl Acad Sci U S A. 111:16472. PubMed
  200. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  201. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  202. Shibata K, et al. 2022. Nat Commun. 13:6948. PubMed
  203. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  204. Gupta SS, et al. 2019. Cell Rep. 29:1862. PubMed
  205. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  206. Liu QZ, et al. 2018. Front Immunol. 1.131944444. PubMed
  207. Nair N, et al. 2020. Curr Protoc Microbiol. 59:e127. PubMed
  208. Ma C, et al. 2021. Signal Transduct Target Ther. 6:353. PubMed
  209. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  210. Limon JJ et al. 2019. Cell host & microbe. 25(3):377-388 . PubMed
  211. Li J, et al. 2022. Int J Biol Sci. 18:2091. PubMed
  212. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  213. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  214. Voga M, et al. 2021. Front Vet Sci. 7:610240. PubMed
  215. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  216. Yasuoka T, et al. 2016. PLoS One. 11: 0157395. PubMed
  217. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  218. García Nores GD, et al. 2018. Nat Commun. 9:1970. PubMed
  219. Ogawa C et al. 2018. Cell reports. 25(1):19-28 . PubMed
  220. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
  221. Harada Y, et al. 2022. iScience. 25:104021. PubMed
  222. Flaherty S, Reynolds J 2015. J Vis Exp. 98: 52739. PubMed
  223. Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed
  224. Sumigray KD et al. 2018. Developmental cell. 45(2):183-197 . PubMed
  225. Liu H, et al. 2022. Nat Commun. 13:3684. PubMed
  226. Li J, et al. 2020. Cancer Discov. . PubMed
  227. Pereira JL, et al. 2021. Transl Oncol. 14:101125. PubMed
  228. Geiger R, et al. 2016. Cell. 167:829-842. PubMed
  229. Arandjelovic S, et al. 2010. J Leukoc Biol. 88:737. PubMed
  230. Lo PK, et al. 2018. Elife. 7:e31334. PubMed
  231. Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
  232. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  233. Han Y, et al. 2019. Am J Cancer Res. 9:800. PubMed
  234. Yang K, et al. 2022. J Clin Invest. 132:. PubMed
  235. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  236. Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed
  237. Skordos I, et al. 2021. STAR Protocols. 2(1):100351. PubMed
  238. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  239. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  240. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  241. Uhde A, et al. 2016. PLoS One. 11: 0161883. PubMed
  242. Kim HR, et al. 2018. Nat Commun. 9:3630. PubMed
  243. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  244. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  245. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  246. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  247. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  248. Garhyan J, et al. 2015. Am J Pathol. 185: 1924-1934. PubMed
  249. Dai B, et al. 2012. Mol Ther. 20:1800. PubMed
  250. Place D, et al. 2017. PLoS One. 10.1371/journal.pone.0190384. PubMed
  251. Bankoti R, et al. 2017. Sci Rep. 10.1038/s41598-017-12171-3. PubMed
  252. Florêncio KGD, et al. 2022. Front Immunol. 13:941757. PubMed
  253. Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
  254. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  255. Kang DW, et al. 2020. J Pathol. 252:304. PubMed
  256. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  257. Flosbach M, et al. 2020. Cell Reports. 32(4):107957. PubMed
  258. Daly CS, et al. 2018. Oncol Rep. 39:483. PubMed
  259. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  260. Naik A, et al. 2015. J Immunol. 194:790. PubMed
  261. Godavarthy PS, et al. 2019. Haematologica. 104(10). PubMed
  262. Clark GC, et al. 2022. Front Oncol. 12:913656. PubMed
  263. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  264. Long H, et al. 2022. Oncol Lett. 23:95. PubMed
  265. Wang YT, et al. 2020. Nat Microbiol. 0.397222222. PubMed
  266. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  267. Pastushenko I, et al. 2020. Nature. 589:448. PubMed
  268. Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
  269. Karandikar SH, et al. 2019. JCI Insight. 5. PubMed
  270. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  271. Cañadas I, et al. 2018. Nat Med. 24:1143. PubMed
  272. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  273. Guo S, et al. 2021. Sci Rep. 11:23745. PubMed
  274. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  275. Li J, et al. 2022. Nat Commun. 13:4032. PubMed
  276. Fei W, et al. 2022. Int J Stem Cells. :. PubMed
  277. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  278. Thakur A, et al. 2018. Front Immunol. 2.336805556. PubMed
  279. Jimenez H, et al. 2019. EBioMedicine. 44:209. PubMed
  280. Revathikumar P, et al. 2018. PLoS One. 13:e0193210. PubMed
  281. King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed
  282. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  283. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  284. Zhang H, et al. 2021. Cell Reports. 35(6):109096. PubMed
  285. Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
  286. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  287. Shissler SC, et al. 2020. Sci Rep. 10:8218. PubMed
  288. Yamazaki M, et al. 2021. Biomedicines. 9:. PubMed
  289. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  290. Jeljeli M, et al. 2021. Front Immunol. 12:670776. PubMed
  291. Tian Q, et al. 2022. Cell Death Dis. 13:71. PubMed
  292. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  293. Li M, et al. 2021. Br J Pharmacol. 178:2617. PubMed
  294. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  295. Lau J, et al. 2015. Cancer Res . 75: 4302 - 4311. PubMed
  296. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  297. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  298. Byrne K, et al. 2014. J Immunol. 192:1433. PubMed
  299. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  300. Xu Y, et al. 2016. Nat Commun. 7:12073. PubMed
  301. Kobayashi A, et al. 2011. J Exp Med. 208:2641. PubMed
  302. Hwang WL, et al. 2019. J Hematol Oncol. 12:10. PubMed
  303. Sun Y, et al. 2020. J Immunol. 205:2649. PubMed
  304. Mizuno M, et al. 2021. Cancers (Basel). 13:. PubMed
  305. Norgard RJ, et al. 2021. EMBO Rep. 22:e51872. PubMed
  306. Parks CA, et al. 2019. Proc Natl Acad Sci U S A. 116:3136. PubMed
  307. Shah D, et al. 2018. Clin Cancer Res. 24:4566. PubMed
  308. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  309. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  310. Weber K, et al. 2008. J Immunol. 180:1442. PubMed
  311. Gejman RS et al. 2018. eLife. 7 pii: e41090. PubMed
  312. Deptuch T, et al. 2022. Sci Rep. 12:13480. PubMed
  313. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  314. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  315. Funk KE, et al. 2021. Aging Cell. 20:e13412. PubMed
  316. Gawish R, et al. 2022. Elife. 11:. PubMed
  317. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  318. Guo S, et al. 2021. Frontiers in Immunology. 11:614667. PubMed
  319. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  320. Liu WL, et al. 2019. Nat Commun. 10:3199. PubMed
  321. Cao Y, et al. 2022. Small. 18:e2203466. PubMed
  322. Plaza-Sirvent C, et al. 2021. Front Immunol. 12:705436. PubMed
  323. Wang W, et al. 2022. Oxid Med Cell Longev. 2022:8172866. PubMed
  324. Swanson WB, et al. 2021. Biomaterials. 272:120769. PubMed
RRID
AB_312962 (BioLegend Cat. No. 103011)
AB_312963 (BioLegend Cat. No. 103012)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark YG™ 581 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark NIR™ 685 anti-mouse/human CD44 (Flexi-Fluor™) Antibody IM7 FC
Spark UV™ 387 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
StarBright UltraViolet 795 anti-mouse/human CD44 IM7 FC
Go To Top Version: 2    Revision Date: 09/11/2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account